Evaluation of the sensitivity and specificity of MCH and MCV for screening of Beta thalassemia minor

Document Type: Original Article


1 Cancer and Immunology Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran

2 Department of Hematology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran

3 High Institution for Research and Education in Transfusion Medicine, Tehran, Iran

4 Hematology and Blood Banking, School of Allied Medicine, Tehran University of Medical Science, Tehran, Iran

5 Stem Cell and Tissue Engineering Research Center, Shahroud University of Medical Sciences, Shahroud, Iran


Introduction:  Beta thalassemia minor (BTM) is a hypochromic and microcytic anemia that is determined by reduced mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). The important screening methods for this disease are lack of patient recovery after 2 months of iron therapy and increased Hemoglobin A2 (HbA2). In this study, we evaluated the sensitivity and specificity of MCH and MCV for diagnosis of BTM.
Methods: This cross-sectional study was performed among patients with BTM. CBC samples were taken and hematological parameters were measured. Two months of iron therapy and measurement of HbA2 were carried out for definitive diagnosis of beta-thalassemia. After definitive diagnosis, the specificity, sensitivity, positive predictive value (PPV) and negative predictive value (NPV) for MCV and MCH were calculated. To investigate the relationship between HbA2 and hematological parameters (MCV and MCH), the linear regression test was performed using the SPSS18 software.
Results: From 300 patients, 154 (51.3%) were men and 146 (48.7%) women. According to the results, the highest sensitivity was associated with MCH with 90% sensitivity and specificity, respectively. Linear regression analysis showed the negative correlation -0.53 and -0.51 between HbA2 and MCV, and MCH, respectively.
Conclusion: According to the results, using parameters like MCH are more appropriate than time consuming and expensive HbA2 measurements for diagnosis of BTM. However, none of the aforementioned parameters showed 100% specificity and sensitivity.


1. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):11. doi:10.1186/1750-1172-5-11
2. Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. Disorders of hemoglobin: genetics, pathophysiology and clinical management: Cambridge University Press; 2009.
3. Taher AT, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev. 2008;22(5):283-92. doi:10.1016/j.blre.2008.04.001
4. Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;12(2):61-76.
5. Asadov C, Mamedova T, Kulieva E, Shakhguseĭnova S. Diagnosis of beta-thalassemia. Klin Lab Diagn. 2004(5):45-7. PMID:15230118
6. Boehm CD, Antonarakis SE, Phillips III JA, Stetten G, Kazazian Jr HH. Prenatal diagnosis using DNA polymorphisms: report on 95 pregnancies at risk for sickle-cell disease or β-thalassemia. N Engl J Med. 1983;308(18):1054-8. doi:10.1056/NEJM198305053081803
7. Clarke GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem. 2000;46(8):1284-90.
8. Tuzmen S, Schechter A. Genetic diseases of hemoglobin: diagnostic methods for elucidating β-thalassemia mutations. Blood Rev. 2001;15(1):19-29. doi:10.1054/blre.2001.0147
9. Pirastu M, Kan YW, Cao A, Conner BJ, Teplitz RL, Wallace RB. Prenatal diagnosis of β-thalassemia: detection of a single nucleotide mutation in DNA. N Engl J Med. 1983;309(5):284-7. doi:10.1056/NEJM198308043090506
10. Miri M, Tabrizi Namini M, Hadipour Dehshal M, Sadeghian Varnosfaderani F, Ahmadvand A, Yousefi Darestani S, et al. Thalassemia in Iran in last twenty years: the carrier rates and the births trend. Ir J Blood Cancer. 2013;6(1):11-7.
11. Karimi M, Rasekhi A. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. Haematologia. 2002;32(2):129-33. doi:10.1163/156855902320387961
12. Pranpanus S, Sirichotiyakul S, Srisupundit K, Tongsong T. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait. J Med Assoc Thai. 2009;92(6):739.
13. Beyan C, Kaptan K, Ifran A. Predictive value of discrimination indices in differential diagnosis of iron deficiency anemia and beta‐thalassemia trait. Eur J Haematol. 2007;78(6):524-6. doi:10.1111/j.1600-0609.2007.00853.x
14. Tari K, Atashi A, Karami F, Kiani Nodeh F, Shahjahani M. Evaluation of the formulae based on red blood cell indices in differentiating between iron deficiency anemia and beta thalasemia minor. Int J Med Lab. 2015;2(3):188-193.